VarmX

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

Total raised

€48M

€47,500,000

Funding rounds

Investors

distinct backers

Active since

2021-10

latest 2023-05

Funding by year

EUR raised per year

High confidence

Raise-next likelihood39

base rate 48% for Series B

Exit likelihood14

base rate 12% (2+ rounds)

Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2023-05-25	Series B	€30M	European Innovation Council (EIC),Sound Bioventures	View deal →
2021-10-21	Other	€18M	European Innovation Council (EIC)	View deal →

same sector or country